Ads
related to: AXLACombination of great tools, asset classes, & low costs - Investopedia
Search results
Axcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the...
Zacks via Yahoo Finance· 1 year agoAxcella Health Inc. (AXLA) is technically in oversold territory now, so the heavy selling pressure...
Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug
Zacks via Yahoo Finance· 8 months agoAxcella (AXLA) shares surge 299% after the company secures a methods-of-use patent for its lead...
Institutions profited after Axcella Health Inc.'s (NASDAQ:AXLA) market cap rose US$35m last week...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Axcella Health Inc. (NASDAQ:AXLA), then you'll have to look...
Axcella (AXLA) Up on Decision to Prioritize Long-COVID Program
Zacks via Yahoo Finance· 2 years agoAxcella (AXLA) re-prioritizes its clinical portfolio to focus on the development of AXA1125...
Are Medical Stocks Lagging Axcella Health (AXLA) This Year?
Zacks via Yahoo Finance· 7 months agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
Great news for Axcella Health Inc. (NASDAQ:AXLA): Insiders acquired stock in large numbers last year
Simply Wall St. via Yahoo Finance· 1 year agoWhen a single insider purchases stock, it is typically not a major deal. However, when multiple...
Why Are Axcella Health Shares Gaining Today?
Benzinga via Yahoo Finance· 1 year agoAxcella Health Inc (NASDAQ: AXLA) announced a regulatory path to the registration of AXA1125 for Long COVID Fatigue. The company received regulatory...
Axcella's NASH Candidate Shows Favorable Action In Long COVID-Related Fatigue
Benzinga via Yahoo Finance· 2 years agoAxcella Health Inc (NASDAQ: AXLA) has reported topline results from the Phase 2a study to evaluate...
Axcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial
Benzinga via Yahoo Finance· 2 years agoAxcella Therapeutics (NASDAQ: AXLA) reported interim results from its ongoing global Phase 2b...
Axcella Therapeutics Puts Development Of NASH Program Aside, Reduces Workforce By 85%
Benzinga via Yahoo Finance· 1 year agoAxcella Health Inc (NASDAQ: AXLA) announced organizational and program updates, including a...
